Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System

Stopped early · Phase 2

Conditions studied: Rhabdoid Neoplasm of CNS

In brief

RATIONALE: Current therapies for childhood Rhabdoid tumors provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of childhood Rhabdoid tumors. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on children (\> 6 months of age) with Rhabdoid tumors.

Key facts

Study ID

NCT00003469

Run by

Burzynski Research Institute

People needed

4

Starts

1996-02-01

Expected to finish

2003-05-01

Last updated by the study team

2017-08-24

Who can join

Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.